Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00461851
Status:
COMPLETED
Last Update Posted:
2017-12-14
First Post:
2007-04-16
Brief Title:
Trial of Gemcitabine Carboplatin and Sorafenib in Chemotherapy-naive Patients With AdvancedMetastatic Bladder Carcinoma
Sponsor:
Yale University
Organization:
Yale University
Organization Data
Organization:
Yale University
Class:
OTHER
Study ID:
0609001823
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Yale University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |